COMPARISON OF ORAL PROSTAGLANDIN E₂ AND INTRAVENOUS OXYTOCIN FOR INDUCTION OF LABOURCICHTENEGGER W; LAHOUSEN M; KRAEMER H et al.1981; GYNECOL. OBSTET. INVEST.; ISSN 0378-7346; CHE; DA. 1981; VOL. 12; NO 4; PP. 197-202; BIBL. 5 REF.Article

THE SIGNIFICANCE OF LYMPHADENECTOMY IN THERAPY OF OVARIAN CARCINOMA = LA SIGNIFICATION DE LA LYMPHADENECTOMIE DANS LE TRAITEMENT DU CANCER DE L'OVAIREBURGHARDT E; PICKEL H; HOLZER E et al.1983; AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY; ISSN 0002-9378; USA; DA. 1983; VOL. 146; NO 1; PP. 111-112; BIBL. 4 REF.; FIGArticle

Partus nach konservativer Therapie eines Rhabdomyosarkoms der Zervix = Successful pregnancy after conservative treatment of botryoid embryonal rhabdomyosarcoma of the uterine cervix. A case reportREICH, O; LAHOUSEN, M; WINTER, R et al.Geburtshilfe und Frauenheilkunde. 2001, Vol 61, Num 1, pp 39-41, issn 0016-5751Article

Borderlinetumoren des Ovars : Darstellung eines sich entwickelnden Konzeptes = Borderline tumors of the ovary: An evolving conceptREICH, O; LAHOUSEN, M; PICKEL, H et al.Geburtshilfe und Frauenheilkunde. 1999, Vol 59, Num 10, pp 488-494, issn 0016-5751Article

Prognostic factors in cervical cancerPICKEL, H; HAAS, J; LAHOUSEN, M et al.European journal of obstetrics, gynecology, and reproductive biology. 1997, Vol 71, Num 2, pp 209-213, issn 0301-2115Conference Paper

Patterns of pelvic and paraaortic lymph node involvement in ovarian cancerBURGHARDT, E; GIRARDI, F; LAHOUSEN, M et al.Gynecologic oncology (Print). 1991, Vol 40, Num 2, pp 103-106, issn 0090-8258, 4 p.Article

The predictive value of a combination of tumor markers in monitoring patients with ovarian cancerLAHOUSEN, M; STETTNER, H; PICKEL, H et al.Cancer. 1987, Vol 60, Num 9, pp 2228-2232, issn 0008-543XArticle

Primäres, papilläres seröses Karzinom des Peritoneums; ein Erfahrungsbericht = Experience with primary, serous papillary carcinoma of the peritoneumPETRU, E; HEYDARFADAI, M; PICKEL, H et al.Geburtshilfe und Frauenheilkunde. 1992, Vol 52, Num 9, pp 533-535, issn 0016-5751Article

Epoetin alfa in platinum-treated ovarian cancer patients : results of a multinational, multicentre, randomised trialWILKINSON, P. M; ANTONOPOULOS, M; LAHOUSEN, M et al.British journal of cancer. 2006, Vol 94, Num 7, pp 947-954, issn 0007-0920, 8 p.Article

Clear cell carcinoma of the uterine cervix : Pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrolREICH, O; TAMUSSINO, K; LAHOUSEN, M et al.Gynecologic oncology (Print). 2000, Vol 76, Num 3, pp 331-335, issn 0090-8258Article

Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancerPICKEL, H; LAHOUSEN, M; PETRU, E et al.Gynecologic oncology (Print). 1999, Vol 72, Num 2, pp 215-219, issn 0090-8258Article

Nongenital cancers metastatic to the ovaryPETRU, E; PICKEL, H; HEYDARFADAI, M et al.Gynecologic oncology (Print). 1992, Vol 44, Num 1, pp 83-86, issn 0090-8258Article

Pretherapeutic scalene lymph node biopsy in ovarian cancerPETRU, E; PICKEL, H; TAMUSSINO, K et al.Gynecologic oncology (Print). 1991, Vol 43, Num 3, pp 262-264, issn 0090-8258Article

Tumor progression, histologic grading and DNA-ploidy as predictive factors of lymphogenous metastasis in primary carcinoma of the Fallopian tubeKLEIN, M; GRAF, A.-H; ROSEN, A et al.Cancer letters. 2002, Vol 177, Num 2, pp 209-214, issn 0304-3835Article

Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies : A prospective, randomized, double-blind placebo-controlled multicenter studyKURZ, C; MARTH, C; WINDBICHLER, G et al.Gynecologic oncology (Print). 1997, Vol 65, Num 3, pp 461-466, issn 0090-8258Article

A 15-year overview of management and prognosis in primary Fallopian tube carcinomaROSEN, A. C; AUSCH, C; HAFNER, E et al.European journal of cancer (1990). 1998, Vol 34, Num 11, pp 1725-1729, issn 0959-8049Article

Diagnosis and surgical treatment of cervical cancerBURGHARDT, E; WINTER, R; TAMUSSINO, K et al.Critical reviews in oncology/hematology. 1994, Vol 17, Num 3, pp 181-231, issn 1040-8428Article

A randomised, double-bind, parallel-group study to compare the efficacy and safety of ondansetron (GR38032F) plus dexamethasone with metoclopramide plus dexamethasone in the prophylaxis of nausea and emesis induced by carboplatin chemotherapyDU BOIS, A; MCKENNA, C. J; ANDERSSON, H et al.Oncology. 1997, Vol 54, Num 1, pp 7-14, issn 0030-2414Article

DNA ploidy in primary Fallopian-tube carcinoma using image cytometryROSEN, A. C; GRAF, A. H; KLEIN, M et al.International journal of cancer. 1994, Vol 58, Num 3, pp 362-365, issn 0020-7136Article

Tumor angiogenesis as a prognostic factor in ovarian carcinoma : Quantification of endothelial immunoreactivity by image analysisSCHOELL, W. M. J; PIEBER, D; REICH, O et al.Cancer. 1997, Vol 80, Num 12, pp 2257-2262, issn 0008-543XArticle

Consolidation radiotherapy following carboplatin-based chemotherapy in radically operated advanced ovarian cancer : a pilot studyPICKEL, H; PETRU, E; LAHOUSEN, M et al.American journal of clinical oncology. 1991, Vol 14, Num 3, pp 184-187, issn 0277-3732Article

Decrease in labile S-S- bridges of serum IgG indicates a shift in IgG subclasses associated with malignancySCHAUENSTEIN, E; REITER, M; SMOLA, M. G et al.Journal of tumor marker oncology. 1989, Vol 4, Num 3, pp 231-237, issn 0886-3849Article

The tumor-associated shift in immunoglobulin G1/G2 is expressed at the messenger RNA level of peripheral blood B lymphocytes in patients with gynecologic malignanciesFELSNER, P; STEINSCHIFTER, W; FISCHER, M et al.Cancer. 2000, Vol 88, Num 2, pp 461-467, issn 0008-543XArticle

Das primäre Tubenkarzinom : eine österreichische Multizenterstudie = The primary carcinoma of the Fallopian tube An austrian multi-centre studyROSEN, A; KLEIN, M; KAHN, K et al.Geburtshilfe und Frauenheilkunde. 1993, Vol 53, Num 5, pp 321-325, issn 0016-5751Article

Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinomaHOFSTRA, L. S; KRISTENSEN, G. B; SLUITER, W. J et al.Journal of clinical oncology. 1998, Vol 16, Num 10, pp 3335-3344, issn 0732-183XArticle